Recommendation
1
2.19 The
committee recommends that the Australian Government reconsider its commitment
to the Pharmacy Rules and investigate options to enhance competition in the
delivery of pharmaceuticals listed on the Pharmaceutical Benefits Scheme, with
priority given to consumers rather than pharmacy owners.
Recommendation
2
2.26 The
committee recommends that the Australian Government investigate options to
align the payment of Goods and Services Tax with business practices, to enable
small businesses to better manage cash flow issues.
Recommendation
3
2.28 The
committee recommends that the Australian Government:
-
investigate
the extent to which community pharmacies are exposed to unnecessary costs as a
result of government policies in relation to the supply of pharmaceutical
benefits; and
-
implement
measures to ensure that community pharmacies are not inadvertently exposed to
costs arising from wholesalers' compliance with regulatory requirements.
Recommendation
4
2.46 The
committee recommends that the Australian Government develop a centralised
electronic system for the PBS Safety Net, similar to the Medicare Safety Net.
Recommendation
5
2.47 The
committee recommends that the Department of Health consider the proposal for
two new digital portals to track the prescribing and dispensing of medicines;
and to trade, track and supply pharmaceuticals on the Pharmaceutical Benefits
Scheme and the Repatriation Pharmaceutical Benefits Scheme.
Recommendation
6
2.58 The
committee recommends that the Australian Government, through the Council of
Australian Governments:
-
investigate
and consider options for progressing uniform medicines legislation; and
-
review
restrictions on ownership of pharmacies and whether they serve the interests of
the public rather than established owners.
Navigation: Previous Page | Contents | Next Page